Furthermore, the nanoparticles’ surface could be modified with active ligands, such as folic acid, hyaluronic acid, chondroitin sulfate, and lactoferrin, for selective and efficient accumulation at tumor sites via targeting specific receptors overexpressed on BC cells [26]. The gene discussed is LTF; the disease is breast cancer.